Keyphrases
Growth Factors
100%
Insulin-like
100%
Protease
100%
Infected Patients
100%
AIDS/HIV
100%
Binding Protein
100%
Growth Hormone Binding Protein
100%
Growth Factor Binding
100%
Lipodystrophy
100%
IGF-binding protein-3
54%
Growth Hormone
36%
Insulin-like Growth Factor Binding Protein (IGFBP)
36%
Age-adjusted
9%
Antiretroviral Therapy
9%
Human Immunodeficiency Virus Infection
9%
Insulin Sensitivity
9%
Serum Samples
9%
Hormone-sensitive
9%
Growth Hormone Treatment
9%
Suppressed Growth
9%
Impaired Growth
9%
Bioactive
9%
Dose-response Study
9%
Abdominal Fat
9%
Insulin Concentration
9%
Insulin-like Growth Factor 2 (IGF2)
9%
Overnight Fasting
9%
Infection Therapy
9%
Growth Hormone Resistance
9%
Mass Concentration
9%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Proteinase
100%
Binding Protein
100%
Somatomedin
100%
Somatomedin Binding Protein
100%
Growth Hormone Binding Protein
100%
Somatomedin Binding Protein 3
100%
Lipodystrophy
53%
Growth Hormone
46%
Synapsin II
46%
Somatomedin C
38%
HIV Associated Lipodystrophy
30%
Synapsin I
15%
Dose-Response Study
7%
Human Immunodeficiency Virus Infection
7%
Somatomedin B
7%
Hormone Resistance
7%
Biochemistry, Genetics and Molecular Biology
Protease
100%
Human Immunodeficiency Virus
100%
Binding Protein
100%
Insulin-Like Growth Factor-Binding Protein
100%
Insulin-Like Growth Factor
100%
Growth Hormone-Binding Protein
100%
Insulin-Like Growth Factor 1
38%
Bovine Somatotropin
38%
Growth Hormone
38%
Synapsin I
15%
Dose Response
7%
Insulin Sensitivity
7%
Fat Mass
7%
Growth Hormone Release
7%
Insulin-Like Growth Factor 2
7%
Immunology and Microbiology
Protein Binding
100%
Human Immunodeficiency Virus
100%
Hormone Binding
100%
Somatomedin
100%
Somatomedin C
27%
Dose Response
5%
Human Immunodeficiency Virus Infection
5%
Insulin Sensitivity
5%
Abdominal Fat
5%
Fat Mass
5%
Growth Hormone Release
5%
Hormone Resistance
5%
Somatomedin B
5%